DexCom
DXCM
263 hedge funds and large institutions have $5.34B invested in DexCom in 2016 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 96 increasing their positions, 101 reducing their positions, and 54 closing their positions.
64% more call options, than puts
Call options by funds: $13.2M | Put options by funds: $8.04M
40% more funds holding in top 10
Funds holding in top 10: 5 → 7 (+2)
5% less repeat investments, than reductions
Existing positions increased: 96 | Existing positions reduced: 101
8% less funds holding
Funds holding: 286 → 263 (-23)
14% less capital invested
Capital invested by funds: $6.21B → $5.34B (-$871M)
35% less first-time investments, than exits
New positions opened: 35 | Existing positions closed: 54
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$267M |
| 2 |
HM
HealthCor Management
New York
|
+$68.5M |
| 3 |
BM
Bridger Management
New York
|
+$37.1M |
| 4 |
Viking Global Investors
Stamford,
Connecticut
|
+$32.5M |
| 5 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$32.3M |
Top Sellers
| 1 |
Winslow Capital Management
Minneapolis,
Minnesota
|
-$271M |
| 2 |
First Trust Advisors
Wheaton,
Illinois
|
-$47.5M |
| 3 |
CCM
Cadian Capital Management
New York
|
-$19.7M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$19.6M |
| 5 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$17.2M |
DXCM Hedge Fund Activity: Q1 2016 in Review
263 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in DexCom (DXCM) for Q1 2016, worth a combined $5.34B — down 14% from $6.21B a quarter earlier.
Sellers outnumbered buyers: 54 funds closed out of DXCM and 35 opened new positions — a net loss of 19 holders — while 101 trimmed existing stakes and 96 added.
The largest buyer was Wellington Management Group, adding an estimated $267M. The largest seller was Winslow Capital Management, exiting entirely with an estimated $271M sold.
- 263 institutional investors held DexCom (DXCM) as of Q1 2016, down from 286 in Q4 2015.
- Funds reported $5.34B of DexCom stock for Q1 2016, down 14% quarter-over-quarter.
- 35 funds opened new DexCom positions in Q1 2016 and 54 closed out, a net change of -19 holders.
- The largest DexCom buyer in Q1 2016 was Wellington Management Group, an estimated $267M added.
- The largest DexCom seller in Q1 2016 was Winslow Capital Management, an estimated $271M sold.
Based on aggregated 13F filings for Q1 2016.